Potential molecular basis of the chondroprotective effect of Harpagophytum procumbens

Phytomedicine

Volumn 13, Issue 8, 2006, Pages 598-600

  Chrubasik, J E ^a,b   Lindhorst, E ^c   Neumann, E ^a   Gerlach, U ^b   Faller Marquardt, M ^b   Torda, T ^d   Muller Ladner U ^a   Chrubasik, S ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HARPAGOPHYTUM PROCUMBENS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICULAR CARTILAGE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HARPAGOPHYTUM PROCUMENS; LETTER; MEDICINAL PLANT; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RABBIT; STATISTICAL SIGNIFICANCE;

ANIMALS; CARTILAGE, ARTICULAR; FEMALE; HARPAGOPHYTUM; KNEE JOINT; OSTEOARTHRITIS, KNEE; PHYTOTHERAPY; PLANT EXTRACTS; RABBITS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

HARPAGOPHYTUM PROCUMBENS;

EID: 33747137548     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2006.01.014     Document Type: Letter

References (11)

1. Anonymus, 2003. Harpagophyti radix. In: ESCOP Monographs (Eds.), European Scientific Cooperative on Phytotherapy. Thieme-Verlag, Stuttgart, New York, pp. 233-240.
2. Boje K., Lechtenberg M., and Nahrstedt A. New and known iridoid- and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase. Planta Med. 69 (2003) 820-825
3. ®. Phytomedicine 9 (2002) 181-194
4. Chrubasik S., Conradt C., and Black A. The quality of clinical trials with Harpagophytum procumbens. Phytomedicine 10 (2003) 613-623
5. R for low back pain. Phytomedicine 11 (2005) 470-477
6. Fiebich B.L., Heinrich M., Hiller K.O., and Kammerer N. Inhibition of TNF-α synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69. Phytomedicine 8 (2001) 28-30
7. Huang T.H., Tran V.H., Duke R.K., Tan S., Chrubasik S., Roufogalis B.D., and Duke C.C. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kB activation. J. Ethnopharmacol. 13 (2005) 11-15
8. Jang M.H., Lim S., Han S.M., Park H.J., Shin I., Kim J.W., Kim N.J., Lee J.S., Kim K.A., and Kim C.J. Harpagophytum procumbens suppresses lipopolysaccharide-stimulated expressions of cyclooxygenase-2 and inducible nitric oxide synthase in fibroblast cell line L929. J. Pharmacol. Sci. 93 (2003) 367-371
9. Loew D., Mollerfeld J., Schrodter A., Puttkammer S., and Kaszkin M. Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo. Clin. Pharmacol. Ther. 69 (2001) 356-364
10. Schulze-Tanzil G., Hansen C., and Shakibaei M. Effect of a Harpagophytum procumbens DC extract on matrix metalloproteinases in human chondrocytes in vitro. Arzneimittel-Forsch. 54 (2004) 213-220
11. Zorn, B., 1958. Über die antiarthritische Wirkung der Harpagophytum-Wurzel. Deutsche. Rheumaforschung. 134-138.